A combination chemotherapy, temozolomide (TMZ) with etoposide (VP), in relapsed or refractory pediatric solid cancer: Preliminary report of randomized phase II study of two different outpatient setting regimens (rPII).
Atsushi Ogawa
No relevant relationships to disclose
Hiroshi Kawamoto
No relevant relationships to disclose
Mari Saito Oba
No relevant relationships to disclose
Ako Hosono
No relevant relationships to disclose
Yoshiyuki Kosaka
No relevant relationships to disclose
Junichi Hara
No relevant relationships to disclose
Yuji Ishida
No relevant relationships to disclose
Kenji Yamada
No relevant relationships to disclose
Katsuyoshi Koh
No relevant relationships to disclose
Yasuhiro Okamoto
No relevant relationships to disclose
Hideo Mugishima
No relevant relationships to disclose
Atsushi Kikuta
No relevant relationships to disclose
Takashi Taga
No relevant relationships to disclose